To include your compound in the COVID-19 Resource Center, submit it here.

Algeta, Avipep deal

Algeta and Avipep partnered to develop a targeted thorium conjugate (TTC)

Read the full 112 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE